These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 9203661)
21. Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC. Jauris-Heipke S; Liegl G; Preac-Mursic V; Rössler D; Schwab E; Soutschek E; Will G; Wilske B J Clin Microbiol; 1995 Jul; 33(7):1860-6. PubMed ID: 7665660 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of outer surface proteins A and C by individual Borrelia burgdorferi in different genospecies. Fingerle V; Laux H; Munderloh UG; Schulte-Spechtel U; Wilske B Med Microbiol Immunol; 2000 Nov; 189(2):59-66. PubMed ID: 11138638 [TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine. Edelman R; Palmer K; Russ KG; Secrest HP; Becker JA; Bodison SA; Perry JG; Sills AR; Barbour AG; Luke CJ; Hanson MS; Stover CK; Burlein JE; Bansal GP; Connor EM; Koenig S Vaccine; 1999 Feb; 17(7-8):904-14. PubMed ID: 10067697 [TBL] [Abstract][Full Text] [Related]
24. A recombinant vaccine for Lyme disease. Wallich R; Kramer MD; Simon MM Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503 [TBL] [Abstract][Full Text] [Related]
25. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi. Luke CJ; Huebner RC; Kasmiersky V; Barbour AG Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476 [TBL] [Abstract][Full Text] [Related]
26. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Fawcett PT; Rose CD; Budd SM; Gibney KM Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199 [TBL] [Abstract][Full Text] [Related]
27. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340 [TBL] [Abstract][Full Text] [Related]
28. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061 [TBL] [Abstract][Full Text] [Related]
29. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Hughes CA; Engstrom SM; Coleman LA; Kodner CB; Johnson RC Infect Immun; 1993 Dec; 61(12):5115-22. PubMed ID: 8225588 [TBL] [Abstract][Full Text] [Related]
30. Vaccination as a modality to prevent Lyme disease. A status report. Wormser GP Infect Dis Clin North Am; 1999 Mar; 13(1):135-48, vii. PubMed ID: 10198796 [TBL] [Abstract][Full Text] [Related]
31. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781 [TBL] [Abstract][Full Text] [Related]
32. Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi. Jauris-Heipke S; Fuchs R; Motz M; Preac-Mursic V; Schwab E; Soutschek E; Will G; Wilske B Med Microbiol Immunol; 1993 Mar; 182(1):37-50. PubMed ID: 8098841 [TBL] [Abstract][Full Text] [Related]
33. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis. Magnarelli LA; Fikrig E; Padula SJ; Anderson JF; Flavell RA J Clin Microbiol; 1996 Feb; 34(2):237-40. PubMed ID: 8788993 [TBL] [Abstract][Full Text] [Related]
34. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Ohnishi J; Piesman J; de Silva AM Proc Natl Acad Sci U S A; 2001 Jan; 98(2):670-5. PubMed ID: 11209063 [TBL] [Abstract][Full Text] [Related]
35. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Fikrig E; Tao H; Kantor FS; Barthold SW; Flavell RA Proc Natl Acad Sci U S A; 1993 May; 90(9):4092-6. PubMed ID: 7683420 [TBL] [Abstract][Full Text] [Related]
36. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332 [TBL] [Abstract][Full Text] [Related]
37. Consensus sequence on the genes encoding the major outer surface proteins (OspA and OspB) of Borrelia garinii isolate. Wang J; Masuzawa T; Komikado T; Yanagihara Y Microbiol Immunol; 1997; 41(2):83-91. PubMed ID: 9087950 [TBL] [Abstract][Full Text] [Related]
38. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Bunikis J; Barbour AG Infect Immun; 1999 Jun; 67(6):2874-83. PubMed ID: 10338494 [TBL] [Abstract][Full Text] [Related]
39. Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. Häupl T; Landgraf S; Netusil P; Biller N; Capiau C; Desmons P; Hauser P; Burmester GR FEMS Immunol Med Microbiol; 1997 Sep; 19(1):15-23. PubMed ID: 9322065 [TBL] [Abstract][Full Text] [Related]
40. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses. Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]